Ba\u015fkanl\u0131\u011f\u0131n\u0131 Prof. Dr. Adil Mardino\u011flu ve Genel Sekreterli\u011fini Prof. Dr. Hasan T\u00fcrkez\u2019in yapt\u0131\u011f\u0131 T\u00fcrkiye Sa\u011fl\u0131k Enstit\u00fcleri Ba\u015fkanl\u0131\u011f\u0131 (T\u00dcSEB) taraf\u0131ndan yeni y\u00f6netim d\u00f6neminde ba\u015flat\u0131lan yenilik\u00e7i ve \u00fcr\u00fcn odakl\u0131 proje \u00e7a\u011fr\u0131lar\u0131na bir yenisi daha eklendi.<\/p>\n
Yenilik\u00e7i \u0130la\u00e7 Geli\u015ftirme Stratejik Ar-Ge Proje \u00c7a\u011fr\u0131s\u0131 ba\u015fl\u0131\u011f\u0131 alt\u0131nda \u00e7\u0131k\u0131lan ve 14.10.2019 tarihinde ba\u015fvuru s\u00fcresi sonlanacak olan \u00e7a\u011fr\u0131n\u0131n amac\u0131n\u0131n yeni ila\u00e7 etken maddelerinin klinik \u00f6ncesi (pre-klinik) \u00e7al\u0131\u015fmalar\u0131n\u0131n desteklenmesi olarak belirtildi.<\/p>\n
Bu kapsamda, do\u011fal, sentetik, biyolojik, biyoteknolojik ve di\u011fer etken maddelere y\u00f6nelik proje \u00f6nerilerinin de\u011ferlendirilece\u011fi ifade edilen a\u00e7\u0131klamada, \u201c\u00c7a\u011fr\u0131 kapsam\u0131nda sunulacak proje \u00f6nerilerinin yenilik\u00e7i olmas\u0131 ve katma de\u011feri y\u00fcksek \u00fcr\u00fcn potansiyeli ta\u015f\u0131mas\u0131 beklenmektedir. Ayr\u0131ca, projeler b\u00fcnyesinde sanayi-\u00fcniversite i\u015f birli\u011finin ger\u00e7ekle\u015ftirilmesi te\u015fvik edilecektir\u201d denildi.<\/p>\n
T\u00dcSEB taraf\u0131ndan yap\u0131lan yaz\u0131l\u0131 a\u00e7\u0131klamada ilgili \u00e7a\u011fr\u0131n\u0131n kapsam\u0131 tan\u0131mland\u0131\u011f\u0131 belirtilerek, \u015fu bilgiler payla\u015f\u0131ld\u0131; \u201cTedavi, \u00f6nleme, te\u015fhis veya bir fizyolojik fonksiyonu d\u00fczeltme, d\u00fczenleme veya de\u011fi\u015ftirme amac\u0131yla, sadece insana uygulanan farmas\u00f6tik ve biyofarmas\u00f6tik \u00fcr\u00fcnlerin d\u00fcnya standartlar\u0131nda yerli olarak \u00fcretilmesi stratejik bir gereklilik olarak kar\u015f\u0131m\u0131za \u00e7\u0131kmaktad\u0131r. Yenilik\u00e7i, etkin h\u00fccresel tedavi \u00fcr\u00fcnlerinin geli\u015ftirilmesi ve \u00fcretilmesi, h\u00fccre ve doku odakl\u0131 \u00e7oklu omik yakla\u015f\u0131mlar ve biyoteknolojik ara\u015ft\u0131rmalar ile bunlara paralel ilerleyen klinik uygulanabilirli\u011fe d\u00f6n\u00fck doku m\u00fchendisli\u011fi, biyomalzeme ve benzeri teknolojiler sayesinde art\u0131k m\u00fcmk\u00fcnd\u00fcr.<\/p>\n
\u00dclkemizde, h\u00fccresel tedavi \u00fcr\u00fcnlerinin geli\u015ftirilmesi ve \u00fcretilmesi i\u00e7in bilimsel ve teknolojik potansiyelin harekete ge\u00e7irilmesine gerek duyulmaktad\u0131r. Yerli farmas\u00f6tik ve biyofarmas\u00f6tik \u00fcr\u00fcnlerin \u00fcretimi alan\u0131nda yap\u0131lacak Ar-Ge \u00e7al\u0131\u015fmalar\u0131n\u0131n desteklenmesi, teknoloji transferinin ger\u00e7ekle\u015ftirilmesi, yat\u0131r\u0131m ve tesisle\u015fme hem sa\u011fl\u0131k hem de ekonomi a\u00e7\u0131dan \u00f6nemli olup, ila\u00e7 geli\u015ftirme alan\u0131nda \u00e7\u0131k\u0131lacak olan proje \u00e7a\u011fr\u0131lar\u0131 ile yerli ve milli ila\u00e7 geli\u015ftirilmesine destek sa\u011flamak T\u00dcSEB\u2019in stratejik hedeflerinden biridir. Bu \u00e7a\u011fr\u0131 program\u0131 ile ulusal sa\u011fl\u0131k sekt\u00f6r\u00fcn\u00fcn ihtiya\u00e7 duydu\u011fu nitelikteki yenilik\u00e7i ila\u00e7 geli\u015ftirme \u00e7al\u0131\u015fmalar\u0131na destek sa\u011flanmas\u0131 ama\u00e7lanmaktad\u0131r. Desteklenmesi planlanan ara\u015ft\u0131rmalar\u0131n kamu-\u00fcniversite-sanayi i\u015fbirli\u011fi i\u00e7erisinde ger\u00e7ekle\u015ftirilmesi ve proje \u00f6nerilerinin do\u011fal, sentetik, biyolojik, biyoteknolojik ve di\u011fer etken maddelerin klinik \u00f6ncesi in vitro ve in vivo ara\u015ft\u0131rmalar\u0131 i\u00e7ermesi beklenmektedir\u201d denilmektedir.<\/p>\n
Yenilik\u00e7i \u0130la\u00e7 Geli\u015ftirme Stratejik Ar-Ge Proje \u00c7a\u011fr\u0131s\u0131 kapsam\u0131nda yer alabilecek konular; hastal\u0131klara y\u00f6nelik etken molek\u00fcllerin geli\u015ftirilmesi, belirli bir hedef i\u00e7in yap\u0131 bazl\u0131 ila\u00e7 tasar\u0131m\u0131 veya fragman bazl\u0131 ila\u00e7 ke\u015ffi y\u00f6ntemleriyle yeni molek\u00fcllerin geli\u015ftirilmesi ve yap\u0131-aktivite ara\u015ft\u0131rmalar\u0131n\u0131n ger\u00e7ekle\u015ftirilmesi, yeni molek\u00fcllerin in vitro etkinlik ve toksikolojik \u00e7al\u0131\u015fmalar\u0131n\u0131n yap\u0131lmas\u0131, yeni molek\u00fcllerin in vivo hayvan modellerinde DMPK ve ADME \u00e7al\u0131\u015fmalar\u0131n\u0131n yap\u0131lmas\u0131 ve hedefe y\u00f6nelik se\u00e7icilik ve \u00f6zg\u00fcnl\u00fc\u011f\u00fcn\u00fcn g\u00f6sterilmesi, yeni molek\u00fcllerin in vivo hayvan modellerinde etkinlik ve toksikolojik profilinin ara\u015ft\u0131r\u0131lmas\u0131 olarak belirtilmi\u015f olup kardiyovask\u00fcler hastal\u0131klar, merkezi sinir sistemi hastal\u0131klar\u0131, metabolik hastal\u0131klar, kanser, otoimm\u00fcn hastal\u0131klar, hematolojik ve nadir hastal\u0131klar gibi alanlarda \u00e7al\u0131\u015fmalar i\u00e7eren projelere \u00f6ncelikli olarak destek verilecektir.<\/p>\n
Ba\u015fvuru yapabilecek kurum\/kurulu\u015f\/ki\u015filer olarak T\u00fcrkiye\u2019de yerle\u015fik \u00fcniversite, \u00f6zel kurulu\u015f, kamu kurum ve kurulu\u015flar\u0131 y\u00fcr\u00fct\u00fcc\u00fc kurulu\u015f olabilecektir. Proje y\u00fcr\u00fct\u00fcc\u00fcs\u00fcn\u00fcn; \u00fcniversite veya kamu kurum\/kurulu\u015fu personeli olmas\u0131 durumunda en az doktora\/t\u0131pta uzmanl\u0131k derecesine sahip olmas\u0131 (bu ko\u015ful e\u011fitim ve ara\u015ft\u0131rma hastanelerinde g\u00f6rev yapanlar\u0131 da kapsamaktad\u0131r), \u00f6zel kurulu\u015f personeli olmas\u0131 halinde en az 4 y\u0131ll\u0131k lisans mezunu olmas\u0131 gerekmektedir. 2019 y\u0131l\u0131 i\u00e7in, ara\u015ft\u0131rma projeleri destek \u00fcst limiti (Proje Te\u015fvik \u0130kramiyesi (PT\u0130) ve Kurum hissesi hari\u00e7) 1 milyon TL\u2019dir.\u201d<\/p>\n","protected":false},"excerpt":{"rendered":"
BA\u015eKANLI\u011eINI PROF. DR. AD\u0130L MARD\u0130NO\u011eLU VE GENEL SEKRETERL\u0130\u011e\u0130N\u0130 PROF. DR. HASAN T\u00dcRKEZ\u2019\u0130N YAPTI\u011eI T\u00dcRK\u0130YE SA\u011eLIK ENST\u0130T\u00dcLER\u0130 BA\u015eKANLI\u011eI (T\u00dcSEB) TARAFINDAN YEN\u0130 Y\u00d6NET\u0130M D\u00d6NEM\u0130NDE BA\u015eLATILAN YEN\u0130L\u0130K\u00c7\u0130 VE \u00dcR\u00dcN ODAKLI PROJE \u00c7A\u011eRILARINA B\u0130R YEN\u0130S\u0130 DAHA EKLEND\u0130.<\/p>\n","protected":false},"author":1,"featured_media":199100,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2},"jetpack_post_was_ever_published":false},"categories":[1],"tags":[2561,6991,5140,7621,3712,1456,13106,49995],"class_list":["post-199099","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-genel","tag-yenilikci","tag-ar-ge","tag-cagrisi","tag-gelistirme","tag-ilac","tag-proje","tag-stratejik","tag-tusebden"],"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/i0.wp.com\/www.tvturk.com\/wp-content\/uploads\/2019\/09\/tusebden-yenilikci-ilac-gelistirme-stratejik-ar-ge-proje-cagrisi_fd5c927.jpg?fit=1000%2C562","jetpack_sharing_enabled":true,"jetpack_shortlink":"https:\/\/wp.me\/paKIfm-PNh","_links":{"self":[{"href":"http:\/\/www.tvturk.com\/index.php\/wp-json\/wp\/v2\/posts\/199099","targetHints":{"allow":["GET"]}}],"collection":[{"href":"http:\/\/www.tvturk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"http:\/\/www.tvturk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"http:\/\/www.tvturk.com\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"http:\/\/www.tvturk.com\/index.php\/wp-json\/wp\/v2\/comments?post=199099"}],"version-history":[{"count":0,"href":"http:\/\/www.tvturk.com\/index.php\/wp-json\/wp\/v2\/posts\/199099\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"http:\/\/www.tvturk.com\/index.php\/wp-json\/wp\/v2\/media\/199100"}],"wp:attachment":[{"href":"http:\/\/www.tvturk.com\/index.php\/wp-json\/wp\/v2\/media?parent=199099"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"http:\/\/www.tvturk.com\/index.php\/wp-json\/wp\/v2\/categories?post=199099"},{"taxonomy":"post_tag","embeddable":true,"href":"http:\/\/www.tvturk.com\/index.php\/wp-json\/wp\/v2\/tags?post=199099"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}